Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. China
  4. Shanghai Stock Exchange
  5. WuXi AppTec Co., Ltd.
  6. Summary
    603259   CNE1000031K4

WUXI APPTEC CO., LTD.

(603259)
  Report
End-of-day quote Shanghai Stock Exchange  -  2022-06-30
102.80 CNY   -1.14%
06/22Sirona Biochem Contracts WuXi AppTec to Manufacture Anti-Aging Compound for Clinical Trial; Pursues Licensing Deal
MT
06/16WuXi ATU and Wugen Announce Manufacturing Partnership to Expedite the Delivery of Novel Cell Cancer Immunotherapies
AQ
06/13WuXi Apptec's Founder Affiliates to Offload Up to 3% Stake in Firm; Shares Plunge 10%
MT
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shanghai Stock Exchange
06/27/2022 06/28/2022 06/29/2022 06/30/2022 07/01/2022 Date
103.46 102.15 101.43 103.99 102.8 Last
36200220 23500520 21958750 25647800 18685300 Volume
+0.77% -1.27% -0.70% +2.52% -1.14% Change
Estimated financial data (e)
Sales 2022 38 383 M 5 728 M 5 728 M
Net income 2022 7 828 M 1 168 M 1 168 M
Net cash position 2022 7 003 M 1 045 M 1 045 M
P/E ratio 2022 38,2x
Yield 2022 0,69%
Sales 2023 46 465 M 6 934 M 6 934 M
Net income 2023 9 841 M 1 469 M 1 469 M
Net cash position 2023 8 801 M 1 313 M 1 313 M
P/E ratio 2023 31,1x
Yield 2023 0,85%
Capitalization 299 B 44 566 M 44 566 M
EV / Sales 2022 7,60x
EV / Sales 2023 6,24x
Nbr of Employees 36 997
Free-Float 63,7%
More Financials
Company
WuXi AppTec Co., Ltd. specializes in providing a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical and biotech industries worldwide to advance discoveries and deliver groundbreaking treatments to patients. Net sales break down by activity as follows: - laboratory services (60.9%): small molecules discovery services, bioanalytical services, medical devices safety testing... 
Read more
More about the company
Ratings of WuXi AppTec Co., Ltd.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B-
More Ratings
All news about WUXI APPTEC CO., LTD.
06/22Sirona Biochem Contracts WuXi AppTec to Manufacture Anti-Aging Compound for Clinical Tr..
MT
06/16WuXi ATU and Wugen Announce Manufacturing Partnership to Expedite the Delivery of Novel..
AQ
06/13WuXi Apptec's Founder Affiliates to Offload Up to 3% Stake in Firm; Shares Plunge 10%
MT
06/12WuXi AppTec Falls Sharply as Shareholders Plan to Sell Stake
DJ
06/05WuXi AppTec Co., Ltd. Reiterates Earnings Guidance for the Second Quarter of 2022
CI
05/25WuXi AppTec Co., Ltd. Announces Management Changes
CI
05/17WuXi Apptec Eyes Issue of Over 78 Million Shares in Hong Kong Under Mandate
MT
05/06WuXi AppTec Co., Appoints Minzhang Chen as Director
CI
05/06WuXi AppTec Co Announces Dividend for 2021, Expected Payable Date of H Shareholders Jun..
CI
04/28UBS Adjusts WuXi AppTec's Price Target to HK$173 From HK$192, Keeps at Buy
MT
04/26WuXi AppTec's Q1 Profit Rises 9.5% on Revenue Growth; Shares Jump 6%
MT
04/25WUXI APPTEC : First Quarter 2022 Results Presentation
PU
04/11WUXI APPTEC : POSITIVE PROFIT ALERT for First Quarter 2022 Results
PU
04/10WuXi AppTec Co., Ltd. Provides Earnings Guidance for the First Quarter Ended March 31, ..
CI
04/07WUXI APPTEC : Recognized as Top-Rated ESG Company by Sustainalytics
PU
More news
News in other languages on WUXI APPTEC CO., LTD.
06/22Sirona Biochem confie à WuXi AppTec la fabrication d'un composé anti-âge destiné à un e..
06/13Le fondateur affilié de WuXi Apptec va céder jusqu'à 3 % de sa participation dans la so..
06/05WuXi AppTec Co., Ltd. réitère ses prévisions de bénéfices pour le deuxième trimestre de..
05/25WuXi AppTec Co., Ltd. annonce des changements de direction
05/17WuXi Apptec envisage l'émission de plus de 78 millions d'actions à Hong Kong dans le ca..
More news
Analyst Recommendations on WUXI APPTEC CO., LTD.
More recommendations
Chart WUXI APPTEC CO., LTD.
Duration : Period :
WuXi AppTec Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends WUXI APPTEC CO., LTD.
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 21
Last Close Price 102,80 CNY
Average target price 156,29 CNY
Spread / Average Target 52,0%
EPS Revisions
Managers and Directors
Min Zhang Chen Co-Chief Executive Officer & Executive Director
Qing Yang Co-CEO, Executive Director & Executive VP
Ge Li Chairman & President
Ellis Chu Co-Chief Financial Officer & Senior Vice President
Ming Shi Co-Chief Financial Officer
Sector and Competitors
1st jan.Capi. (M$)
WUXI APPTEC CO., LTD.-13.31%44 566
GILEAD SCIENCES, INC.-14.12%78 219
VERTEX PHARMACEUTICALS30.84%73 484
REGENERON PHARMACEUTICALS, INC.-5.72%64 152
BIONTECH SE-38.91%38 276
GENMAB A/S-10.23%21 607